Rapid immunochromatographic test for simultaneous detection of COVID-19 and influenza A/B antigens from respiratory specimens. Delivers results in 15-20 minutes, enabling quick differential diagnosis in clinical and point-of-care settings. Single-use test cassette with high sensitivity and specifici...
Manufactured by
NewScen Coast Bio-Pharmaceutical Co., Ltd.
China
NewScen Coast Bio-Pharmaceutical Co., Ltd., established in 2003, is a leading POCT manufacturer listed on China's NEEQ (Stock Code: 872334). The company produces rapid diagnostic products covering cardiac markers, infection, tumor, and infectious disease testing, serving over 110 domestic medical institutions and exporting to 20+ countries. In 2019, the company established China's first automated microfluidic chip production line for immunoassay applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Healgen Scientific LLC
United States · 2 relevant products
Biopanda Reagents
United Kingdom · 4 relevant products
Beijing Jinwofu Bioengineering Technology Co.,Ltd.
China · 4 relevant products
71 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →13 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 118 closest product alternatives
Healgen Scientific LLC · United States
Rapid diagnostic test for simultaneous detection of influenza A/B and coronavirus antigens from nasopharyngeal or oropharyngeal specimens. CLIA-waived immunofluorescence assay enabling point-of-care results within minutes for respiratory pathogen screening and patient triage.
Biopanda Reagents · United Kingdom
An immunochromatographic assay for qualitative detection of SARS-CoV-2 nucleocapsid protein and Influenza A+B virus antigens in nasal and nasopharyngeal swab samples. It is intended to assist in the diagnosis of SARS-CoV-2 and Influenza A+B infections in conjunction with other tests.
Beijing Jinwofu Bioengineering Technology Co.,Ltd. · China
A rapid antigen test kit for simultaneous detection of Influenza A, Influenza B, and COVID-19 (SARS-CoV-2). This combo test enables efficient screening for multiple respiratory viruses in a single procedure.
115 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products